InvestSMART

Avecho Biotechnology Limited (ASX: AVE) - Announcements

Current share price for AVE : $0.019 0.001 (5%)+

ASX company news and announcements for Avecho Biotechnology Limited (AVE) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Avecho Biotechnology Limited (AVE) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Avecho Biotechnology Limited (AVE), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Avecho Biotechnology Limited (AVE)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$73 Avecho signs Term Sheet for Cannabinoid Supply with Purisys 14 Apr 2020 8:39AM $0.004 $0.019 risen by 375%
$73 Chairman's Address 9 Apr 2020 8:35AM $0.002 $0.019 risen by 850%
$73 Deferral of Annual General Meeting 25 Mar 2020 5:01PM $0.003 $0.019 risen by 660%
$73 Date of AGM and Closing Date for Nomination of Director 17 Mar 2020 5:08PM $0.003 $0.019 risen by 533.33%
$73 Change of Director's Interest Notice 2 Mar 2020 3:03PM $0.004 $0.019 risen by 375%
$73 Lapse of Unlisted Options 2 Mar 2020 2:59PM $0.004 $0.019 risen by 375%
$73 Appendix 4G and Corporate Governance Statement 2 Mar 2020 9:11AM $0.003 $0.019 risen by 533.33%
$73 Appendix 4E and Annual Report 31 December 2019 2 Mar 2020 9:04AM $0.003 $0.019 risen by 533.33%
$73 Appendix 4C - Quarterly 23 Jan 2020 8:49AM $0.004 $0.019 risen by 375%
$73 Initial Director's Interest Notice 13 Jan 2020 8:39AM $0.004 $0.019 risen by 375%
$73 Appointment of New Director 13 Jan 2020 8:36AM $0.004 $0.019 risen by 375%
$73 Injectable Portfolio Update - Products Differentiated by TPM 4 Dec 2019 11:48AM $0.004 $0.019 risen by 375%
$73 Change in substantial holding 22 Oct 2019 2:37PM $0.005 $0.019 risen by 280%
$73 Terumo return rights to TPM/Propofol Injectable 17 Oct 2019 8:31AM $0.006 $0.019 risen by 216.67%
$73 Appendix 4C - Quarterly 10 Oct 2019 8:29AM $0.006 $0.019 risen by 216.67%
$73 Securities Trading Policy 30 Aug 2019 8:35AM $0.004 $0.019 risen by 375%
$73 Appendix 4D and Half-year Financial Report 30 Aug 2019 8:31AM $0.004 $0.019 risen by 375%
$73 Appendix 4C - Quarterly 22 Jul 2019 8:34AM $0.004 $0.019 risen by 375%
$73 Resignation of Joint Company Secretary 19 Jul 2019 10:59AM $0.004 $0.019 risen by 442.86%
$73 Ashland purchases manufacturing rights for Vital ET and TPM 20 Jun 2019 9:12AM $0.003 $0.019 risen by 533.33%
$73 Suspension from Official Quotation 15 Nov 2010 4:52PM $1.770 $0.019 fallen by 98.93%
$73 SGP: Commencement of Compulsory Acquisition 15 Nov 2010 3:21PM $1.770 $0.019 fallen by 98.93%
$73 SGP: Extension of Aevum Offer 12 Nov 2010 2:13PM $1.770 $0.019 fallen by 98.93%
$73 SGP: Notice of Variation Extending Offer Period-Aevum 29 Oct 2010 5:28PM $1.770 $0.019 fallen by 98.93%
$73 Third Supplementary Target`s Statement 7 Oct 2010 5:25PM $1.770 $0.019 fallen by 98.93%

226 - 250 of 312 results

Page 10 of 13

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.